TY - JOUR
T1 - Technologies will not make diabetes disappear
T2 - how to integrate the concept of diabetes distress into care
AU - Fagherazzi, Guy
N1 - Funding Information:
Guy Fagherazzi (GF) is supported by the Luxembourg Institute of Health. GF previously received honorary fees, as a consultant, speaker, or board member from MSD, Lilly, Roche Diabetes Care, AstraZeneca, Danone Research, Diabeloop, Bristol Myers Squibb, L'Oréal R&D, Abbvie Pharmaceutical, Pfizer, Akuity Care. Some parts of this article have been generated with ChatGPT (OpenAI), used as a writing assistant, but were then rewritten and completed by the author. GF fully endorses the content of this manuscript and considers it as his own production.
Publisher Copyright:
© 2023
PY - 2023/7/1
Y1 - 2023/7/1
N2 - Diabetes epidemiology has evolved rapidly since the 90 s and so are the technologies for diabetes treatment and care. With each new innovation coming to the market, hopes that technologies will solve the numerous, complex, issues related to diabetes are present. However, if it is now demonstrated that, overall, those technologies - when available - bring major benefits to people living with diabetes, they do not make the disease disappear. In this short review, we discuss the interconnections between technologies and diabetes distress, an often underlooked consequence of the continuous demands of diabetes. We define the concept of diabetes distress, discuss which dimensions can be positively impacted thanks to the use of diabetes technologies and what will likely not be solved by them. With the emergence of closed-loop insulin delivery systems, it is of utmost importance to give sufficient space to the assessment of the emotional dimension of diabetes care in clinical routine.
AB - Diabetes epidemiology has evolved rapidly since the 90 s and so are the technologies for diabetes treatment and care. With each new innovation coming to the market, hopes that technologies will solve the numerous, complex, issues related to diabetes are present. However, if it is now demonstrated that, overall, those technologies - when available - bring major benefits to people living with diabetes, they do not make the disease disappear. In this short review, we discuss the interconnections between technologies and diabetes distress, an often underlooked consequence of the continuous demands of diabetes. We define the concept of diabetes distress, discuss which dimensions can be positively impacted thanks to the use of diabetes technologies and what will likely not be solved by them. With the emergence of closed-loop insulin delivery systems, it is of utmost importance to give sufficient space to the assessment of the emotional dimension of diabetes care in clinical routine.
UR - http://www.scopus.com/inward/record.url?scp=85151432397&partnerID=8YFLogxK
U2 - 10.1016/j.deman.2023.100140
DO - 10.1016/j.deman.2023.100140
M3 - Review article
AN - SCOPUS:85151432397
SN - 2666-9706
VL - 11
JO - Diabetes Epidemiology and Management
JF - Diabetes Epidemiology and Management
M1 - 100140
ER -